CI
CX Institutional’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $347K | Buy |
2,743
+2,490
| +984% | +$315K | 0.01% | 464 |
|
|
2025
Q1 | $32K | Buy |
+253
| New | +$32K | ﹤0.01% | 897 |
|
|
2024
Q3 | – | Sell |
-2,856
| Closed | -$392K | – | 571 |
|
|
2024
Q2 | $392K | Buy |
2,856
+21
| +0.7% | +$2.88K | 0.02% | 400 |
|
|
2024
Q1 | $389K | Sell |
2,835
-55
| -2% | -$7.55K | 0.02% | 402 |
|
|
2023
Q4 | $393K | Buy |
+2,890
| New | +$393K | 0.02% | 358 |
|
|
2023
Q3 | – | Sell |
-6,756
| Closed | -$858K | – | 511 |
|
|
2023
Q2 | $858K | Buy |
6,756
+263
| +4% | +$33.4K | 0.04% | 293 |
|
|
2023
Q1 | $843K | Sell |
6,493
-28,114
| -81% | -$3.65M | 0.04% | 298 |
|
|
2022
Q4 | $4.54M | Buy |
34,607
+7,938
| +30% | +$1.04M | 0.28% | 95 |
|
|
2022
Q3 | $3.12M | Buy |
26,669
+26,563
| +25,059% | +$3.11M | 0.22% | 113 |
|
|
2022
Q2 | $12K | Buy |
+106
| New | +$12K | ﹤0.01% | 921 |
|
|
2021
Q4 | – | Sell |
-10
| Closed | -$2K | – | 604 |
|
|
2021
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 908 |
|
|
2021
Q2 | $2K | Hold |
10
| – | – | ﹤0.01% | 904 |
|
|
2021
Q1 | $2K | Hold |
10
| – | – | ﹤0.01% | 828 |
|
|
2020
Q4 | $2K | Hold |
10
| – | – | ﹤0.01% | 817 |
|
|
2020
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 845 |
|
|
2020
Q2 | $1K | Sell |
10
-15
| -60% | -$1.5K | ﹤0.01% | 804 |
|
|
2020
Q1 | $3K | Sell |
25
-10
| -29% | -$1.2K | ﹤0.01% | 615 |
|
|
2019
Q4 | $4K | Hold |
35
| – | – | ﹤0.01% | 587 |
|
|
2019
Q3 | $3K | Sell |
35
-28
| -44% | -$2.4K | ﹤0.01% | 672 |
|
|
2019
Q2 | $7K | Sell |
63
-11,091
| -99% | -$1.23M | ﹤0.01% | 550 |
|
|
2019
Q1 | $1.25M | Buy |
+11,154
| New | +$1.25M | 0.22% | 115 |
|
|
2018
Q4 | – | Sell |
-6,032
| Closed | -$736K | – | 544 |
|
|
2018
Q3 | $736K | Buy |
+6,032
| New | +$736K | 0.24% | 90 |
|